インプラント周囲炎市場：タイプ別、エンドユーザー別-2025-2030年の世界予測

インプラント周囲炎市場は、2023年に9億5,671万米ドルと評価され、2024年には10億5,004万米ドルに達すると予測され、CAGR 9.84%で成長し、2030年には18億4,654万米ドルに達すると予測されています。

インプラント周囲炎は、歯科インプラント周囲の組織に影響を及ぼす炎症性疾患であり、高齢化によるインプラント処置の増加や口腔の健康に対する意識の高まりに後押しされ、歯科分野に大きな課題を投げかけています。その定義は、インプラントの安定性を脅かす骨量減少につながる炎症です。インプラント周囲炎に対処する必要性は、歯科インプラントの寿命を損なう可能性があることにあり、強固な予防、診断、治療アプリケーションが必要です。これらのアプリケーションには、抗菌療法、機械的デブリードマン、再生技術が含まれます。エンドユーザーは歯科医院、病院、研究機関など多岐にわたり、ヘルスケア環境における需要の多様性を浮き彫りにしています。市場成長は、歯科技術の進歩、審美的な歯科ソリューションに対する患者の傾向の増加、研究開発への多額の投資といった要因に影響されます。特に、革新的な治療法や再生ソリューションの開発、遺伝子や微生物学的知見を活用した個別化医療アプローチにビジネスチャンスが生じています。歯科医療関係者はまた、早期発見のための高度な診断ツールを求めており、これは市場拡大のための成長ニッチを提示しています。しかし、市場の限界には、高額な治療費、不十分な保険適用、標準化された治療プロトコルの欠如などがあり、これが普及の妨げとなっています。その他の課題としては、インプラント周囲炎を正確に診断し、進行した症例を効果的に治療することの複雑さが挙げられます。より反応性の高いインプラントのためのバイオマテリアル開発、抗菌性表面を強化するナノテクノロジー、予測診断のための機械学習などの分野では、技術革新が極めて重要です。市場の性質は依然として非常にダイナミックであり、歯科学、バイオテクノロジー、材料科学を融合させた学際的コラボレーションには大きな可能性があります。企業は、戦略的パートナーシップ、開業医への継続的な教育、研究開発への多額の投資などに重点を置き、優位性を保つ必要があります。このような次元をうまく乗り切ることで、市場浸透が進み、インプラント周囲炎の治療ソリューションで主導権を握ることができると思われます。

市場力学：急速に進化するインプラント周囲炎市場の主要市場インサイトを公開

インプラント周囲炎市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • インプラント周囲炎の普及率の増加
  • 喫煙および糖尿病人口の急増
  • インプラントの増加に伴う高齢者人口の増加
• 市場抑制要因
  • 手術に関する知識不足と費用
• 市場機会
  • レーザー除染などの技術革新と進歩
• 市場の課題
  • 臨床的限界と機能的課題

ポーターの5つの力：インプラント周囲炎市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：インプラント周囲炎市場における外部からの影響の把握

外部マクロ環境要因は、インプラント周囲炎市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析インプラント周囲炎市場における競合情勢の把握

インプラント周囲炎市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスインプラント周囲炎市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、インプラント周囲炎市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨インプラント周囲炎市場における成功への道筋を描く

インプラント周囲炎市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • インプラント周囲炎の普及率の増加
    • 喫煙や糖尿病になりやすい人口が急増
    • 高齢者人口の増加と歯科インプラントの増加
  • 抑制要因
    • 手術に関する知識不足と費用
  • 機会
    • レーザー除染などの技術革新と進歩
  • 課題
    • 臨床上の限界と機能上の課題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 インプラント周囲炎市場：タイプ別

• 非外科的
  • 抗生物質
  • レーザーデブリードマン
  • 機械的デブリードマン
• 外科手術
  • 骨の再生
  • インプラント形成術
  • オープンフラップデブリードマン

第7章 インプラント周囲炎市場：エンドユーザー別

• 歯科医院
• 病院

第8章 南北アメリカのインプラント周囲炎市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のインプラント周囲炎市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのインプラント周囲炎市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 3M Company
• Aetna Inc.
• Basic Pharma Life Science Pvt Ltd.
• botiss biomaterials GmbH
• Dawood & Tanner by Dentex Manco Limited
• Geistlich Pharma AG
• Healthy Life Pharma Pvt. Ltd.
• Jiangsu Yenssen Biotech Co., Ltd.
• Neoss Limited
• Pfizer Inc.
• Prachi Pharmaceuticals Private Limited.
• Silveraid S.r.l.
• Small Lab Co., Ltd.
• Straumann Group
• vVARDIS AG

LIST OF FIGURES

• FIGURE 1. PERI-IMPLANTITIS MARKET RESEARCH PROCESS
• FIGURE 2. PERI-IMPLANTITIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PERI-IMPLANTITIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PERI-IMPLANTITIS MARKET DYNAMICS
• TABLE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY BONE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANTO-PLASTY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY OPEN FLAP DEBRIDEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 36. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 37. CANADA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 58. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 59. CHINA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 62. INDIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 63. INDIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 131. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 132. ITALY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 147. POLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 148. POLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 151. QATAR PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 152. QATAR PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY NON-SURGICAL, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2023

The Peri-implantitis Market was valued at USD 956.71 million in 2023, expected to reach USD 1,050.04 million in 2024, and is projected to grow at a CAGR of 9.84%, to USD 1,846.54 million by 2030.

Peri-implantitis, an inflammatory condition affecting the tissues around dental implants, poses significant challenges in the field of dentistry, driven by increasing implant procedures due to aging populations and rising awareness of oral health. Its definition covers inflammation leading to bone loss, endangering implant stability. The necessity for addressing peri-implantitis lies in its potential to compromise the longevity of dental implants, necessitating robust prevention, diagnostic, and treatment applications. These applications encompass antimicrobial therapies, mechanical debridement, and regenerative techniques. End-users span dental clinics, hospitals, and research institutions, highlighting the diversified demand across healthcare settings. Market growth is influenced by factors like advancing dental technologies, increasing patient inclination towards aesthetic dental solutions, and substantial investments in R&D. Opportunities emerge particularly in developing innovative treatment modalities and regenerative solutions, along with personalized medicine approaches utilizing genetic and microbiomic insights. Dental professionals also push for advanced diagnostic tools for early detection, which presents a growing niche for market expansion. However, market limitations include high treatment costs, inadequate insurance coverage, and a lack of standardized treatment protocols, which hamper widespread adoption. Other challenging factors involve the complexity of diagnosing peri-implantitis accurately and effectively treating advanced cases. Innovation is crucial in areas like biomaterial development for more responsive implants, nanotechnology for enhanced antimicrobial surfaces, and machine learning for predictive diagnostics. The market's nature remains highly dynamic, with significant potential in interdisciplinary collaborations bringing together dentistry, biotechnology, and materials science. Firms should focus on strategic partnerships, continuous education for practitioners, and investing heavily in R&D to stay ahead. Successfully navigating these dimensions could lead to significant market penetration and leadership in peri-implantitis treatment solutions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Peri-implantitis Market

The Peri-implantitis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of peri-implantitis
  • Burgeoning population prone to smoking and diabetes
  • Rise in elderly populace coupled with increasing dental implants
• Market Restraints
  • Lack of knowledge and cost linked with surgery
• Market Opportunities
  • Technological innovation and advancements such as laser decontamination
• Market Challenges
  • Clinical limitations and functional challenges

Porter's Five Forces: A Strategic Tool for Navigating the Peri-implantitis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Peri-implantitis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Peri-implantitis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Peri-implantitis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Peri-implantitis Market

A detailed market share analysis in the Peri-implantitis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Peri-implantitis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Peri-implantitis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Peri-implantitis Market

A strategic analysis of the Peri-implantitis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Peri-implantitis Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Aetna Inc., Basic Pharma Life Science Pvt Ltd., botiss biomaterials GmbH, Dawood & Tanner by Dentex Manco Limited, Geistlich Pharma AG, Healthy Life Pharma Pvt. Ltd., Jiangsu Yenssen Biotech Co., Ltd., Neoss Limited, Pfizer Inc., Prachi Pharmaceuticals Private Limited., Silveraid S.r.l., Small Lab Co., Ltd., Straumann Group, and vVARDIS AG.

Market Segmentation & Coverage

This research report categorizes the Peri-implantitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Non-Surgical and Surgical. The Non-Surgical is further studied across Antibiotics, Laser Debridement, and Mechanical Debridement. The Surgical is further studied across Bone Regeneration, Implanto-Plasty, and Open Flap Debridement.
• Based on End-User, market is studied across Dental Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of peri-implantitis
    • 5.1.1.2. Burgeoning population prone to smoking and diabetes
    • 5.1.1.3. Rise in elderly populace coupled with increasing dental implants
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of knowledge and cost linked with surgery
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological innovation and advancements such as laser decontamination
  • 5.1.4. Challenges
    • 5.1.4.1. Clinical limitations and functional challenges
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Peri-implantitis Market, by Type

• 6.1. Introduction
• 6.2. Non-Surgical
  • 6.2.1. Antibiotics
  • 6.2.2. Laser Debridement
  • 6.2.3. Mechanical Debridement
• 6.3. Surgical
  • 6.3.1. Bone Regeneration
  • 6.3.2. Implanto-Plasty
  • 6.3.3. Open Flap Debridement

7. Peri-implantitis Market, by End-User

• 7.1. Introduction
• 7.2. Dental Clinics
• 7.3. Hospitals

8. Americas Peri-implantitis Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Peri-implantitis Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Peri-implantitis Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3M Company
• 2. Aetna Inc.
• 3. Basic Pharma Life Science Pvt Ltd.
• 4. botiss biomaterials GmbH
• 5. Dawood & Tanner by Dentex Manco Limited
• 6. Geistlich Pharma AG
• 7. Healthy Life Pharma Pvt. Ltd.
• 8. Jiangsu Yenssen Biotech Co., Ltd.
• 9. Neoss Limited
• 10. Pfizer Inc.
• 11. Prachi Pharmaceuticals Private Limited.
• 12. Silveraid S.r.l.
• 13. Small Lab Co., Ltd.
• 14. Straumann Group
• 15. vVARDIS AG